⌘K

Login Start Free

Home/Filings/4/0001424422-19-000003

4//SEC Filing

Plott Ronald Todd 4

Accession 0001424422-19-000003

CIK 0001504167other

View on SEC.gov Company Profile

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 6:35 PM ET

Size

11.8 KB

Accession

0001424422-19-000003

Insider Transaction Report

Form 4

Period: 2019-02-01

BioPharmX CorpBPMX

Plott Ronald Todd

Director

Transactions

Award
Option to purchase common stock
2019-02-01$0.11/sh+133,000$14,630→ 133,000 total
Exercise: $0.11From: 2019-03-01Exp: 2029-02-01→ Common stock (133,000 underlying)
Award
Option to purchase common stock
2019-02-01$0.11/sh+200,000$22,000→ 333,000 total
Exercise: $0.11From: 2019-03-01Exp: 2029-02-01→ Common stock (200,000 underlying)
Award
Option to purchase common stock
2019-02-01$0.20/sh+51,000$10,200→ 418,000 total
Exercise: $0.20From: 2019-03-01Exp: 2029-02-01→ Common stock (51,000 underlying)
Award
Option to purchase common stock
2019-02-01$0.20/sh+34,000$6,800→ 367,000 total
Exercise: $0.20From: 2019-03-01Exp: 2029-02-01→ Common stock (34,000 underlying)

Footnotes (2)

[F1]This option vests ratably over 4 months with the first vesting starting on 3/1/2019.
[F2]This option vests ratably over 24 months with the first vesting starting on 3/1/2019.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

BioPharmX Corp

CIK 0001504167

Entity typeother

Related Parties

1

filerCIK 0001768337

Filing Metadata

Form type: 4
Filed: Feb 20, 7:00 PM ET
Accepted: Feb 21, 6:35 PM ET
Size: 11.8 KB

View on SEC.gov